Whoop pushed back on the warning letter, claiming its blood pressure feature for a wearable wristband is for “wellness” and ...

The company’s custom implants compete with devices from Medtronic, Johnson & Johnson and Globus Medical.

The defect has resulted in problems including a procedural delay, difficulty removing device fragments and bleeding, the FDA said.

Medical device sales remained a bright spot for the company, however, with more than 20% growth in diabetes devices.

The demonstration of a trans-Atlantic operation using Intuitive Surgical’s da Vinci 5 robot on a tissue model was a focus at ...

The money will also help the company complete enrollment in a randomized controlled trial of patients with newly diagnosed ...

J&J’s electrophysiology group returned to growth in the second quarter after a decline in the prior quarter. Now, can the ...

The orthopedics firm is looking to round out its robotics offerings with the planned $177 million acquisition. Some analysts ...

Medtronic said its market-leading LigaSure technology can now be used with its Hugo soft tissue robotic surgery system in ...

Meanwhile, Brazil announced its own countermeasures while Mexico remains confident it will reach a deal by Aug. 1.

The deal allows Zimmer to sell Getinge’s infection control and surgical products alongside its orthopedic implants and robots ...

The BD business will be spun off and merged with a Waters subsidiary. Waters shares were down about 11% in early trading Monday on the news.